It was reported that HO-1 had a role in the prevention of DN, as HO-1 polymorphism was associated with type 2 diabetes mellitus in humans [48], and eventually DN, suggesting HO-1 as a target for therapy of acute renal injury [49]. This evidence concerns the gene HMOX1 and liver dysplastic nodule.